TruBridge Gross Margin 2011-2025 | TBRG
Current and historical gross margin for TruBridge (TBRG) over the last 10 years. The current gross profit margin for TruBridge as of September 30, 2025 is %.
| TruBridge Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $0.35B | $0.18B | 52.74% |
| 2025-06-30 | $0.35B | $0.18B | 52.31% |
| 2025-03-31 | $0.35B | $0.18B | 51.73% |
| 2024-12-31 | $0.34B | $0.17B | 50.44% |
| 2024-09-30 | $0.34B | $0.17B | 48.96% |
| 2024-06-30 | $0.34B | $0.16B | 48.36% |
| 2024-03-31 | $0.33B | $0.16B | 47.90% |
| 2023-12-31 | $0.34B | $0.16B | 47.62% |
| 2023-09-30 | $0.34B | $0.16B | 47.48% |
| 2023-06-30 | $0.34B | $0.16B | 47.77% |
| 2023-03-31 | $0.34B | $0.16B | 48.36% |
| 2022-12-31 | $0.33B | $0.16B | 49.24% |
| 2022-09-30 | $0.32B | $0.16B | 51.26% |
| 2022-06-30 | $0.31B | $0.16B | 51.80% |
| 2022-03-31 | $0.29B | $0.15B | 51.89% |
| 2021-12-31 | $0.28B | $0.15B | 51.60% |
| 2021-09-30 | $0.27B | $0.14B | 50.73% |
| 2021-06-30 | $0.27B | $0.14B | 51.10% |
| 2021-03-31 | $0.26B | $0.14B | 51.33% |
| 2020-12-31 | $0.27B | $0.14B | 51.32% |
| 2020-09-30 | $0.27B | $0.14B | 51.30% |
| 2020-06-30 | $0.27B | $0.14B | 51.48% |
| 2020-03-31 | $0.28B | $0.14B | 52.17% |
| 2019-12-31 | $0.28B | $0.15B | 52.73% |
| 2019-09-30 | $0.28B | $0.15B | 53.62% |
| 2019-06-30 | $0.28B | $0.15B | 53.62% |
| 2019-03-31 | $0.28B | $0.15B | 53.24% |
| 2018-12-31 | $0.28B | $0.15B | 53.57% |
| 2018-09-30 | $0.29B | $0.15B | 53.85% |
| 2018-06-30 | $0.28B | $0.15B | 53.52% |
| 2018-03-31 | $0.28B | $0.15B | 53.87% |
| 2017-12-31 | $0.28B | $0.15B | 53.07% |
| 2017-09-30 | $0.26B | $0.13B | 50.38% |
| 2017-06-30 | $0.26B | $0.13B | 50.38% |
| 2017-03-31 | $0.26B | $0.13B | 50.00% |
| 2016-12-31 | $0.27B | $0.13B | 50.00% |
| 2016-09-30 | $0.25B | $0.13B | 51.42% |
| 2016-06-30 | $0.23B | $0.12B | 51.54% |
| 2016-03-31 | $0.21B | $0.11B | 51.94% |
| 2015-12-31 | $0.18B | $0.10B | 52.20% |
| 2015-09-30 | $0.18B | $0.11B | 60.33% |
| 2015-06-30 | $0.19B | $0.11B | 58.85% |
| 2015-03-31 | $0.20B | $0.11B | 57.07% |
| 2014-12-31 | $0.20B | $0.11B | 55.39% |
| 2014-09-30 | $0.21B | $0.10B | 47.37% |
| 2014-06-30 | $0.20B | $0.10B | 46.80% |
| 2014-03-31 | $0.20B | $0.10B | 46.80% |
| 2013-12-31 | $0.20B | $0.09B | 46.27% |
| 2013-09-30 | $0.20B | $0.09B | 44.95% |
| 2013-06-30 | $0.20B | $0.09B | 44.90% |
| 2013-03-31 | $0.19B | $0.08B | 43.92% |
| 2012-12-31 | $0.18B | $0.08B | 43.72% |
| 2012-09-30 | $0.18B | $0.08B | 44.07% |
| 2012-06-30 | $0.17B | $0.08B | 44.25% |
| 2012-03-31 | $0.18B | $0.08B | 45.76% |
| 2011-12-31 | $0.17B | $0.08B | 45.66% |
| 2011-09-30 | $0.17B | $0.08B | 45.98% |
| 2011-06-30 | $0.17B | $0.08B | 45.09% |
| 2011-03-31 | $0.16B | $0.07B | 43.21% |
| 2010-12-31 | $0.15B | $0.07B | 42.21% |
| 2010-09-30 | $0.15B | $0.06B | 40.69% |
| 2010-06-30 | $0.14B | $0.06B | 40.88% |
| 2010-03-31 | $0.13B | $0.05B | 40.77% |
| 2009-12-31 | $0.13B | $0.06B | 42.97% |
| 2009-09-30 | $0.13B | $0.06B | 44.44% |
| 2009-06-30 | $0.12B | $0.06B | 44.72% |
| 2009-03-31 | $0.12B | $0.05B | 45.00% |
| 2008-12-31 | $0.12B | $0.05B | 44.17% |
| 2008-09-30 | $0.12B | $0.05B | 43.10% |
| 2008-06-30 | $0.11B | $0.05B | 42.98% |
| 2008-03-31 | $0.11B | $0.05B | 42.98% |
| 2007-12-31 | $0.11B | $0.05B | 42.73% |
| 2007-09-30 | $0.11B | $0.05B | 43.75% |
| 2007-06-30 | $0.11B | $0.05B | 43.24% |
| 2007-03-31 | $0.11B | $0.05B | 43.75% |
| 2006-12-31 | $0.12B | $0.05B | 44.83% |
| 2006-09-30 | $0.11B | $0.05B | 44.74% |
| 2006-06-30 | $0.11B | $0.05B | 44.74% |
| 2006-03-31 | $0.11B | $0.05B | 44.64% |
| 2005-12-31 | $0.11B | $0.05B | 44.44% |
| 2005-09-30 | $0.10B | $0.05B | 44.23% |
| 2005-06-30 | $0.10B | $0.04B | 43.88% |
| 2005-03-31 | $0.09B | $0.04B | 43.33% |
| 2004-12-31 | $0.08B | $0.03B | 40.24% |
| 2004-09-30 | $0.08B | $0.03B | 38.75% |
| 2004-06-30 | $0.08B | $0.03B | 37.97% |
| 2004-03-31 | $0.08B | $0.03B | 37.50% |
| 2003-12-31 | $0.08B | $0.03B | 39.02% |
| 2003-09-30 | $0.08B | $0.03B | 40.00% |
| 2003-06-30 | $0.08B | $0.03B | 41.77% |
| 2003-03-31 | $0.08B | $0.03B | 41.56% |
| 2002-12-31 | $0.07B | $0.03B | 41.89% |
| 2002-09-30 | $0.07B | $0.03B | 40.58% |
| 2002-06-30 | $0.06B | $0.03B | 39.06% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.286B | $0.339B |
| TruBridge Inc. is a healthcare solutions company. TruBridge Inc. is based in MOBILE, Ala. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.476B | 59.15 |
| Tempus AI (TEM) | United States | $12.470B | 0.00 |
| Doximity (DOCS) | United States | $9.841B | 40.73 |
| Hims & Hers Health (HIMS) | United States | $9.345B | 76.02 |
| IRhythm Technologies (IRTC) | United States | $5.680B | 0.00 |
| Hinge Health (HNGE) | United States | $3.475B | 0.00 |
| Privia Health (PRVA) | United States | $2.879B | 180.08 |
| Heartflow (HTFL) | United States | $2.821B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.501B | 41.38 |
| 10x Genomics (TXG) | United States | $2.126B | 0.00 |
| Enovis (ENOV) | United States | $1.731B | 9.09 |
| Omnicell (OMCL) | United States | $1.652B | 33.77 |
| Azenta (AZTA) | United States | $1.387B | 60.52 |
| Phreesia (PHR) | United States | $1.355B | 0.00 |
| Schrodinger (SDGR) | United States | $1.346B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.333B | 0.00 |
| Claritev (CTEV) | United States | $0.953B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.840B | 0.00 |
| Evolent Health (EVH) | United States | $0.582B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Talkspace (TALK) | United States | $0.560B | 112.67 |
| Veradigm (MDRX) | United States | $0.517B | 0.00 |
| Standard BioTools (LAB) | United States | $0.450B | 0.00 |
| Carlsmed (CARL) | United States | $0.335B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.325B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.294B | 0.00 |
| CapsoVision (CV) | United States | $0.231B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.210B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.201B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.195B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.183B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.181B | 0.00 |
| CareCloud (CCLD) | United States | $0.143B | 7.84 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| Pulmonx (LUNG) | United States | $0.079B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.054B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.025B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.000B | 0.00 |